Effect of Prior Atorvastatin Treatment on the Frequency of Hospital Acquired Pneumonia and Evolution of Biomarkers in Patients with Acute Ischemic Stroke: A Multicenter Prospective Study

Table 1

Baseline characteristics of all 492 patients.

Variable	PG ()	NG ()	p
Male gender, (%)	130 (48.51)	108 (48.21)	1.000
Age, yrs	68.34 ± 7.73	67.13 ± 7.82	0.085
Previous medical illness
Cardiovascular disease, (%)	175 (65.30)	123 (54.91)	0.019
Cerebrovascular disease, (%)	110 (41.04)	70 (31.25)	0.025
Position of stroke
TACI, (%)	64 (23.88)	49 (21.88)	0.838
PACI, (%)	51 (19.03)	46 (20.54)
POCI, (%)	68 (25.37)	52 (23.21)
LACI, (%)	85 (31.72)	77 (34.37)
IPPV, (%)	132 (49.25)	101 (49.05)	0.366
Modified CPIS			0.084
GCS			0.085
APACHE II			0.052
PaO2/FiO2 (mmHg)			0.054
Cholesterol (mmol/L)			0.001
LDL (mmol/L)			0.001
ALT (U/L)			0.170
AST (U/L)			0.064
CK (ng/mL)			0.076
WBC (10^9/L)			0.127
PCT (ng/mL)			1.000
TNF-α (ng/L)			0.198
IL-6 (ng/mL)			0.105